Chart, Financials, Historical Prices, Industry, Insider, Messages, Profile, Reports, Research, SEC Filings, more...

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 10-Feb-2010
New Screen 

All Reports | Brokerage Reports | Independent Reports
All Reports (Showing 1 to 10 of 28)
Release
Date [down]		 Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
9-Feb-10Pechala's ReportsLubomir PechalaNATIONAL HEALTH INVESTORS INC (NHI=US) - REPORT FOR ACTIVE TRADERS4$25  View Abstract
8-Feb-10Plunkett Research, Ltd.Jack W. PlunkettReal Estate & Construction Industry Market Research and Competitive Analysis 2009599$299  View Abstract
8-Feb-10Plunkett Research, Ltd.Jack W. PlunkettReal Estate & Construction Industry Trends, Statistics & Analysis 2009 (Summary)64$199  View Abstract
8-Feb-10Market EdgeN/AMarket Edge Equity Research Report4$10  View Abstract
7-Feb-10Pechala's ReportsFrantisek PechalaNATIONAL HEALTH INVESTORS INC (NHI=US) 12-months forecast1$15  View Abstract
6-Feb-10Standard & Poor's Quantitative ReportN/ANatl Health Investors6$25  View Abstract
6-Feb-10Reuters Investment ProfileN/ANila Housing and Infrastructures Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$20  View Abstract
6-Feb-10Reuters Investment ProfileN/ANatunola Health Biosciences Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$20  View Abstract
6-Feb-10Pechala's ReportsLubomir PechalaNATIONAL HEALTH INVESTORS INC (NHI=US) 2-weeks forecast1$10  View Abstract
6-Feb-10Reuters Investment ProfileN/ANational Health Investors Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$20  View Abstract
Next 18
Brokerage Reports (Showing 1 to 4 of 4)
Release
Date [down]		 Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
29-Jan-10Morgan Keegan & Company, Inc.N/AFirst Look - Jan 29 2010 08:00AM12$25  View Abstract
29-Jan-10Morgan Keegan & Company, Inc.Rob M. Mains CFAHealthcare REIMBURSEMENT ALERT: What to Expect from the President's 2011 Budget3$10  View Abstract
15-Jan-10Hilliard LyonsJohn M. RobertsEarnings Preview5$10 5 Stars View Abstract
4-Jan-10Hilliard LyonsJohn M. RobertsThe Healthcare REIT Sector13$50 5 Stars View Abstract
Independent Reports (Showing 1 to 10 of 24)
Release
Date [down]		 Contributor Author Title Pages Price More Info
9-Feb-10Pechala's ReportsLubomir PechalaNATIONAL HEALTH INVESTORS INC (NHI=US) - REPORT FOR ACTIVE TRADERS4$25View Abstract
8-Feb-10Plunkett Research, Ltd.Jack W. PlunkettReal Estate & Construction Industry Market Research and Competitive Analysis 2009599$299View Abstract
8-Feb-10Plunkett Research, Ltd.Jack W. PlunkettReal Estate & Construction Industry Trends, Statistics & Analysis 2009 (Summary)64$199View Abstract
8-Feb-10Market EdgeN/AMarket Edge Equity Research Report4$10View Abstract
7-Feb-10Pechala's ReportsFrantisek PechalaNATIONAL HEALTH INVESTORS INC (NHI=US) 12-months forecast1$15View Abstract
6-Feb-10Standard & Poor's Quantitative ReportN/ANatl Health Investors6$25View Abstract
6-Feb-10Reuters Investment ProfileN/ANila Housing and Infrastructures Ltd: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$20View Abstract
6-Feb-10Reuters Investment ProfileN/ANatunola Health Biosciences Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$20View Abstract
6-Feb-10Pechala's ReportsLubomir PechalaNATIONAL HEALTH INVESTORS INC (NHI=US) 2-weeks forecast1$10View Abstract
6-Feb-10Reuters Investment ProfileN/ANational Health Investors Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.12$20View Abstract
Next 14

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.